← All trials
NCT01631552
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2013
- Primary completion
- Jun 1, 2018
- Completion date
- Jun 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 250
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- ImmunomedicsLead sponsor
- ImmunomedicsStudy chair
Drugs studied
Indications studied
- Squamous Cell Carcinoma of Head and Neck
- Carcinoma, Ovarian Epithelial
- Urinary Bladder Neoplasms
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Uterine Cervical Neoplasms
- Esophageal Neoplasms
- Glioblastoma
- Carcinoma, Hepatocellular
- Pancreatic Neoplasms
- Stomach Neoplasms
- Endometrial Neoplasms
- Small Cell Lung Carcinoma
- Triple Negative Breast Neoplasms
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.